Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers HOLX
Denver Mercury-Free Fillings & SMART Removal: Holistic Dentist Treatments Update
Via Press Release Distribution Service
Exposures Product Safety
Simplifying the Path to CLIA Waiver Certificate: MDC Associates Drives Innovation in Diagnostics
Via Press Release Distribution Service
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at ThinkEquity Conference
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Arbutus Medical Launches Digit Revision SwiftKit™ to Streamline Trauma Care and Improve Emergency Department Throughput
Via PRLog
Exposures Product Safety
Stange Law Firm Hires Divorce & Family Law Attorney Ryan Frantz in Arnold, Missouri
Via AB Newswire
Topics Immigration
Exposures Immigration Product Safety
Veterans Affairs Eyes Funding For New MDMA-PTSD Trial After FDA Setback
Via Benzinga
Exposures Product Safety
Ozempic Can Potentially Cut Risk Of Alzheimer's Compared To Other Diabetic Medicines, Study Shows
Via Benzinga
Exposures Product Safety
Tickers NVO
FDA Launches Investigation Into McDonald's Supplier Taylor Farms Following E. Coli Outbreak
Via Benzinga
Topics Supply Chain
Exposures Product Safety Supply Chain
Tickers MCD
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Mpox Vaccine Research at World Vaccine Congress Europe 2024
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet
Via Investor's Business Daily
Exposures Product Safety
Tickers LLY VKTX
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Different Classes of Medical Devices According to the FDA
Via Syndication Cloud
Exposures Product Safety
Corrective and Preventive Actions (CAPA) in Medical Device Cybersecurity
Via Syndication Cloud
Topics Data Breach
Exposures Information Security Product Safety
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Via Benzinga
Exposures Product Safety
Tickers HIMS LLY NVO
Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
Via Benzinga
Exposures Product Safety
Tickers DBVT
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
Via Benzinga
Exposures Product Safety
Tickers GSK PFE
Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance to Initiate Pivotal Phase 3 Alzheimer’s Studies, Paving the Way for NDA Filings
Via Investor Brand Network
Exposures Product Safety
Tickers ANVS
$1.6M NIH Grant Awarded for the Development of the Kalm Patch
Via Newsfile
Exposures Product Safety
What's Going On With Sangamo Therapeutics Shares Tuesday?
Via Benzinga
Exposures Product Safety
Tickers SGMO
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
Via Benzinga
Exposures Product Safety
Tickers IRTC
From Student-Athlete, to General Contractor, to Chiropractor: Dr. Mark Chiungos Reflects on 25 Years of Serving The Chelmsford Community
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Kaplan Fox & Kilsheimer LLP is Investigating Humacyte, Inc. (HUMA) for Potential Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers HUMA
Kaplan Fox &amp; Kilsheimer LLP is Investigating Humacyte, Inc. (HUMA) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers HUMA
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
Via Benzinga
Exposures Product Safety
Tickers BNTX
Why LENZ Therapeutics Stock Hit A New 52-Week High Today
Via Benzinga
Exposures Product Safety
Tickers LENZ
Humacyte Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Exposures Product Safety
Tickers HUMA
Humacyte Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Exposures Product Safety
Tickers HUMA
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Humacyte, Inc. (HUMA)
Via NewMediaWire
Exposures Product Safety
Tickers HUMA
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.